rs4148512

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005845.5(ABCC4):​c.2455+21715C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.269 in 152,078 control chromosomes in the GnomAD database, including 5,996 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 5996 hom., cov: 32)

Consequence

ABCC4
NM_005845.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.23

Publications

3 publications found
Variant links:
Genes affected
ABCC4 (HGNC:55): (ATP binding cassette subfamily C member 4 (PEL blood group)) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This family member plays a role in cellular detoxification as a pump for its substrate, organic anions. It may also function in prostaglandin-mediated cAMP signaling in ciliogenesis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2014]
ABCC4 Gene-Disease associations (from GenCC):
  • qualitative platelet defect
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005845.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.381 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005845.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCC4
NM_005845.5
MANE Select
c.2455+21715C>T
intron
N/ANP_005836.2O15439-1
ABCC4
NM_001301829.2
c.2314+21715C>T
intron
N/ANP_001288758.1O15439-2
ABCC4
NM_001105515.3
c.2455+21715C>T
intron
N/ANP_001098985.1O15439-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCC4
ENST00000645237.2
MANE Select
c.2455+21715C>T
intron
N/AENSP00000494609.1O15439-1
ABCC4
ENST00000629385.1
TSL:1
c.2455+21715C>T
intron
N/AENSP00000487081.1O15439-3
ABCC4
ENST00000967420.1
c.2455+21715C>T
intron
N/AENSP00000637479.1

Frequencies

GnomAD3 genomes
AF:
0.269
AC:
40915
AN:
151962
Hom.:
5988
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.386
Gnomad AMI
AF:
0.223
Gnomad AMR
AF:
0.286
Gnomad ASJ
AF:
0.237
Gnomad EAS
AF:
0.151
Gnomad SAS
AF:
0.250
Gnomad FIN
AF:
0.218
Gnomad MID
AF:
0.278
Gnomad NFE
AF:
0.214
Gnomad OTH
AF:
0.283
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.269
AC:
40944
AN:
152078
Hom.:
5996
Cov.:
32
AF XY:
0.268
AC XY:
19902
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.386
AC:
15994
AN:
41478
American (AMR)
AF:
0.286
AC:
4375
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.237
AC:
823
AN:
3468
East Asian (EAS)
AF:
0.151
AC:
782
AN:
5168
South Asian (SAS)
AF:
0.251
AC:
1212
AN:
4820
European-Finnish (FIN)
AF:
0.218
AC:
2311
AN:
10580
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.214
AC:
14563
AN:
67962
Other (OTH)
AF:
0.281
AC:
594
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1514
3028
4542
6056
7570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
406
812
1218
1624
2030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.236
Hom.:
14115
Bravo
AF:
0.281
Asia WGS
AF:
0.211
AC:
738
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.44
DANN
Benign
0.27
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4148512;
hg19: chr13-95791728;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.